Three experts resign as FDA advisors over approval of Alzheimer’s drug

Because they are not following their own guidelines. Three experts resign as FDA advisors over approval of Alzheimer’s drug

The advisory committee reviewed the data behind Aduhelm last November and voted overwhelmingly against approval. Of the 11 advisors on the committee, 10 voted “no” on the question of whether Biogen had collected enough evidence to indicate that the drug is effective. The remaining advisor voted “uncertain.”

But the bureaucrats know best, so it was approved.

Trust the science, unless it gets in the way of your friends making money.